% | $
Quotes you view appear here for quick access.

Peregrine Pharmaceuticals, Inc. Message Board

  • cruizon cruizon Feb 14, 2013 7:56 AM Flag

    Treating late term near death patients is tough but Bavi moved the needle

    Bavi works best with a less compromised by repeated chemo immune system.
    AF is a lowlife that prostitutes himself all for the love of money. Will do and say anything and apparently he is effective. Learned at the teet of Jim Cramer who is now attempting to make amends for his past sins, including keeping the justice department at bay.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • ima.pseudonym Feb 14, 2013 8:09 AM Flag

      In terms of mos, we cannot assume they moved the needle. Moving the needle means giving a result (whatever size, however small) that has statistical significance - in other words that we can expect to be repeatable. Yesterday's PR did not include the p-value of the results. Other press releases from pphm have included it. Maybe it was an oversight, but the more realistic assumption is that the results did not meet the statistical threshold. It wasn't just that the mos advantage was small, it was that it was small and they would not expect that result to repeat if they ran the exact same experiment again.

0.4144+0.0044(+1.07%)May 27 4:00 PMEDT